SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-000626
Filing Date
2022-01-04
Accepted
2022-01-04 06:07:33
Documents
2
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2136680-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2136680-2_3seq1.xml 3 1600
2 EXHIBIT 24 tm2136680d2_ex24.htm EX-24 9603
  Complete submission text file 0001104659-22-000626.txt   12783
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4819 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address
Eisenstadt Richard I (Reporting) CIK: 0001515806 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 22503990